Advanced search
Publication Cover
Journal of Medical Economics Volume 27, 2024 - Issue 1
Submit an article Journal homepage
580
Views
0
CrossRef citations to date
0
Altmetric
Oncology

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

Martijn J. H. G. Simonsa Evidence & Access, OPEN Health, Rotterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0001-5248-1676
ORCID Icon,
Peter M. Machielsenb Exact Sciences, Baar, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8056-8063
ORCID Icon,
Jelle A. Spoorendonka Evidence & Access, OPEN Health, Rotterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0003-3687-4968
ORCID Icon,
Tim Ignacioa Evidence & Access, OPEN Health, Rotterdam, The Netherlands
,
Pieter B. Drostb Exact Sciences, Baar, Switzerland
,
Tim Jacobsb Exact Sciences, Baar, Switzerland
&
Felix E. de Jonghc Ikazia Ziekenhuis Rotterdam, Rotterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-1925-6263
ORCID Icon show all
Pages 445-454 | Received 02 Jan 2024, Accepted 26 Feb 2024, Published online: 12 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.